DNA methylation profiling of hepatosplenic T-cell lymphoma.
作者信息
Bergmann Anke K, Fataccioli Virginie, Castellano Giancarlo, Martin-Garcia Nadine, Pelletier Laura, Ammerpohl Ole, Bergmann Juri, Bhat Jaydeep, Pau Enrique Carrillo-de Santa, Martín-Subero José I, Moffitt Andrea B, Valencia Alfonso, Oberg Hans-Heinrich, Wesch Daniela, Jayne Sandrine, Dyer Martin J S, Kabelitz Dieter, Gaulard Philippe, Siebert Reiner
机构信息
Institute of Human Genetics, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Germany
Department of Pediatrics, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Germany.
出版信息
Haematologica. 2019 Mar;104(3):e104-e107. doi: 10.3324/haematol.2018.196196. Epub 2018 Oct 18.
Abstract
摘要
相似文献
1
DNA methylation profiling of hepatosplenic T-cell lymphoma.肝脾T细胞淋巴瘤的DNA甲基化谱分析
Haematologica. 2019 Mar;104(3):e104-e107. doi: 10.3324/haematol.2018.196196. Epub 2018 Oct 18.
2
The curious origins of angioimmunoblastic T-cell lymphoma.血管免疫母细胞性T细胞淋巴瘤的奇特起源
Curr Opin Hematol. 2016 Jul;23(4):434-43. doi: 10.1097/MOH.0000000000000261.
3
Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.Dnmt1 在预防和维持 MYC 诱导的 T 细胞淋巴瘤中的重要作用。
Mol Cell Biol. 2013 Nov;33(21):4321-33. doi: 10.1128/MCB.00776-13. Epub 2013 Sep 3.
4
HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma.HAVCR2突变与皮下脂膜炎样T细胞淋巴瘤中的严重噬血细胞综合征相关。
Blood. 2020 Mar 26;135(13):1058-1061. doi: 10.1182/blood.2019003811.
5
p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.p-MAPK1表达与血管免疫母细胞性T细胞淋巴瘤患者的不良预后相关。
Br J Haematol. 2017 Feb;176(4):661-664. doi: 10.1111/bjh.13972. Epub 2016 Feb 25.
6
Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways.靶向 T 细胞淋巴瘤表观基因组诱导细胞死亡、癌症睾丸抗原、免疫调节信号通路。
Mol Cancer Ther. 2021 Aug;20(8):1422-1430. doi: 10.1158/1535-7163.MCT-20-0377. Epub 2021 Jun 9.
7
CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.淋巴瘤小鼠模型中的CpG岛甲基化由肿瘤细胞的基因构型驱动。
PLoS Genet. 2007 Sep;3(9):1757-69. doi: 10.1371/journal.pgen.0030167. Epub 2007 Aug 16.
8
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.异柠檬酸脱氢酶2（IDH2）R172位点突变定义了血管免疫母细胞性T细胞淋巴瘤患者的一个独特亚组。
Blood. 2015 Oct 8;126(15):1741-52. doi: 10.1182/blood-2015-05-644591. Epub 2015 Aug 12.
9
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.血管免疫母细胞性 T 细胞淋巴瘤中 RHOA 突变的临床病理意义：一项荟萃分析：AITL 中的 RHOA 突变。
Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):431-438. doi: 10.1016/j.clml.2021.03.002. Epub 2021 Mar 19.
10
Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.在多种血液系统恶性肿瘤中，原钙黏蛋白10常因甲基化而发生表观遗传沉默。
Br J Haematol. 2007 Mar;136(6):829-32. doi: 10.1111/j.1365-2141.2007.06512.x.
引用本文的文献
1
Subtyping Burkitt Lymphoma by DNA Methylation.通过DNA甲基化对伯基特淋巴瘤进行亚型分类。
Genes Chromosomes Cancer. 2025 Apr;64(4):e70042. doi: 10.1002/gcc.70042.
2
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.SMARCB1 表达缺失是人类和鼠外周 T 细胞淋巴瘤的一个亚型的特征。
Nat Commun. 2024 Oct 3;15(1):8571. doi: 10.1038/s41467-024-52826-0.
3
Genome-Wide Methylation Profiling of Peripheral T-Cell Lymphomas Identifies TRIP13 as a Critical Driver of Tumor Proliferation and Survival.外周T细胞淋巴瘤的全基因组甲基化分析确定TRIP13是肿瘤增殖和生存的关键驱动因素。
Epigenomes. 2024 Aug 21;8(3):32. doi: 10.3390/epigenomes8030032.
4
Genome-wide methylation profiling of Peripheral T-cell lymphomas identifies TRIP13 as a critical driver of tumor proliferation and survival.外周T细胞淋巴瘤的全基因组甲基化分析确定TRIP13是肿瘤增殖和生存的关键驱动因素。
Res Sq. 2024 Feb 29:rs.3.rs-3971059. doi: 10.21203/rs.3.rs-3971059/v1.
5
Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.结外成熟 T 细胞和 NK 细胞淋巴瘤和淋巴增殖性疾病的生物学和遗传学。
Haematologica. 2023 Dec 1;108(12):3261-3277. doi: 10.3324/haematol.2023.282718.
6
The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.γδ T细胞在癌症中的多样作用：从快速免疫反应到侵袭性淋巴瘤
Cancers (Basel). 2021 Dec 9;13(24):6212. doi: 10.3390/cancers13246212.
7
Deciphering DNA Methylation in HIV Infection.解析 HIV 感染中的 DNA 甲基化。
Front Immunol. 2021 Dec 2;12:795121. doi: 10.3389/fimmu.2021.795121. eCollection 2021.
8
Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.外周 T 细胞淋巴瘤的基因谱和生物标志物：在诊断中的当前作用。
Mod Pathol. 2022 Mar;35(3):306-318. doi: 10.1038/s41379-021-00937-0. Epub 2021 Sep 28.
9
Targeting epigenetic regulators in the treatment of T-cell lymphoma.靶向表观遗传调节因子治疗T细胞淋巴瘤。
Expert Rev Hematol. 2020 Feb;13(2):127-139. doi: 10.1080/17474086.2020.1711732. Epub 2020 Jan 22.
10
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.信号转导和转录激活因子3（STAT3）及信号转导和转录激活因子5（STAT5）的Src同源2（SH2）结构域突变的结构影响
Cancers (Basel). 2019 Nov 8;11(11):1757. doi: 10.3390/cancers11111757.
本文引用的文献
1
The Genetic Basis of Hepatosplenic T-cell Lymphoma.肝脾T细胞淋巴瘤的遗传基础
Cancer Discov. 2017 Apr;7(4):369-379. doi: 10.1158/2159-8290.CD-16-0330. Epub 2017 Jan 25.
2
Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas.γδ肝脾T细胞淋巴瘤中频繁出现的STAT5B突变。
Leukemia. 2014 Nov;28(11):2244-8. doi: 10.1038/leu.2014.200. Epub 2014 Jun 20.
3
Identification of STAT5A and STAT5B target genes in human T cells.人类T细胞中STAT5A和STAT5B靶基因的鉴定。
PLoS One. 2014 Jan 30;9(1):e86790. doi: 10.1371/journal.pone.0086790. eCollection 2014.
4
Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.解析肝脾 T 细胞淋巴瘤的分子特征揭示潜在的新治疗靶点。
Blood. 2012 Jun 14;119(24):5795-806. doi: 10.1182/blood-2011-12-396150. Epub 2012 Apr 17.
5
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms.一项针对 367 种血液系统肿瘤的综合基于微阵列的 DNA 甲基化研究。
PLoS One. 2009 Sep 11;4(9):e6986. doi: 10.1371/journal.pone.0006986.
6
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.通过联合表观基因组、基因组和转录谱分析对成熟侵袭性B细胞淋巴瘤的生物学特性和起源的新见解
Blood. 2009 Mar 12;113(11):2488-97. doi: 10.1182/blood-2008-04-152900. Epub 2008 Dec 15.
7
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.肝脾γδ T细胞淋巴瘤是一种罕见的临床病理实体，预后较差：21例病例系列报告
Blood. 2003 Dec 15;102(13):4261-9. doi: 10.1182/blood-2003-05-1675. Epub 2003 Aug 7.
8
Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.肝脾αβ T细胞淋巴瘤：14例报告并与肝脾γδ T细胞淋巴瘤比较
Am J Surg Pathol. 2001 Mar;25(3):285-96. doi: 10.1097/00000478-200103000-00002.
9
Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.肝脾αβ T细胞淋巴瘤：1例具有γδ肝脾T细胞淋巴瘤临床、组织学及细胞遗传学特征的罕见病例。
Am J Surg Pathol. 2000 Jul;24(7):1027-32. doi: 10.1097/00000478-200007000-00016.
10
Zotero 插件